Option Care Health (NASDAQ:OPCH) Given “Market Perform” Rating at Barrington Research

Barrington Research reiterated their market perform rating on shares of Option Care Health (NASDAQ:OPCH) in a research note issued to investors on Wednesday morning,Benzinga reports.

Several other equities research analysts also recently commented on OPCH. UBS Group reaffirmed a “buy” rating on shares of Option Care Health in a report on Tuesday, September 22nd. Wall Street Zen upgraded Option Care Health from a “hold” rating to a “buy” rating in a report on Saturday, August 1st. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $24.00 price objective (down from $26.00) on shares of Option Care Health in a research note on Thursday, July 30th. Stephens reiterated an “equal weight” rating and issued a $24.00 target price (down from $30.00) on shares of Option Care Health in a report on Friday, July 17th. Finally, Jefferies Financial Group downgraded shares of Option Care Health from a “buy” rating to a “hold” rating and lifted their target price for the stock from $28.00 to $32.05 in a research report on Tuesday. Three analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $29.70.

Option Care Health Trading Up 0.0%

Option Care Health stock opened at $31.01 on Wednesday. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.98 and a current ratio of 1.47. The firm has a market cap of $4.64 billion, a price-to-earnings ratio of 23.32, a price-to-earnings-growth ratio of 1.79 and a beta of 0.58. Option Care Health has a 1 year low of $18.01 and a 1 year high of $36.80. The firm’s 50 day moving average price is $23.92 and its two-hundred day moving average price is $23.57.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings data on Wednesday, July 29th. The company reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. The company had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.42 billion. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%.The company’s quarterly revenue was up 1.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.41 EPS. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. On average, research analysts predict that Option Care Health will post 1.7 EPS for the current fiscal year.

Institutional Trading of Option Care Health

Several large investors have recently made changes to their positions in the stock. Central Pacific Bank Trust Division lifted its holdings in Option Care Health by 3.9% in the 3rd quarter. Central Pacific Bank Trust Division now owns 14,369 shares of the company’s stock worth $323,000 after purchasing an additional 540 shares during the last quarter. Engineers Gate Manager LP grew its holdings in Option Care Health by 263.0% during the second quarter. Engineers Gate Manager LP now owns 43,560 shares of the company’s stock valued at $913,000 after purchasing an additional 31,561 shares during the last quarter. Squarepoint Ops LLC grew its holdings in Option Care Health by 234.1% during the second quarter. Squarepoint Ops LLC now owns 434,408 shares of the company’s stock valued at $9,110,000 after purchasing an additional 304,376 shares during the last quarter. Empirical Finance LLC acquired a new position in Option Care Health during the second quarter valued at approximately $595,000. Finally, Nykredit A S bought a new position in shares of Option Care Health in the second quarter valued at approximately $56,000. Institutional investors own 98.05% of the company’s stock.

Key Option Care Health News

Here are the key news stories impacting Option Care Health this week:

• Positive Sentiment: The definitive acquisition agreement provides a clear cash valuation and near-term potential for shareholders, while the stock’s trading below the $32.05 offer price leaves a merger-arbitrage spread if the transaction closes as planned. CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health
• Positive Sentiment: Unusually heavy call-option activity and trading volume indicate significant speculative interest following the takeover announcement, although these signals do not guarantee additional gains. Option Care Health Rockets as CD&R and McKesson Table 37% Premium Bid
• Neutral Sentiment: JPMorgan reaffirmed a Neutral rating with a $33 price target, while Citizens JMP and Barrington Research maintained Market Perform ratings. The targets suggest limited upside beyond the announced offer and reflect the likelihood that the deal, rather than operating performance, will determine the stock’s value.
• Neutral Sentiment: Investors are booking gains and focusing on deal completion rather than standalone fundamentals. Zacks noted that recent earnings-estimate trends may not support further upside independent of the acquisition. Strength Seen in Option Care
• Negative Sentiment: Several shareholder-rights law firms are investigating whether the $32.05 offer fairly values Option Care Health and whether insiders received benefits unavailable to public shareholders. Such reviews could increase deal-related uncertainty or encourage demands for a higher bid. Ademi LLP OPCH Shareholder Alert

About Option Care Health

Option Care Health, Inc (NASDAQ: OPCH) is a provider of home and alternate-site infusion services in the United States. The company works with patients, physicians, hospitals, health plans and pharmaceutical manufacturers to deliver and manage infusion therapy outside traditional hospital settings, including in patients’ homes, ambulatory infusion suites and other community-based locations.

Its services include the provision and administration of specialty medications and other infusion therapies for conditions such as infections, immune disorders, chronic diseases and nutritional deficiencies.